167 related articles for article (PubMed ID: 20679620)
1. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.
Le Deley MC; Rosolen A; Williams DM; Horibe K; Wrobel G; Attarbaschi A; Zsiros J; Uyttebroeck A; Marky IM; Lamant L; Woessmann W; Pillon M; Hobson R; Mauguen A; Reiter A; Brugières L
J Clin Oncol; 2010 Sep; 28(25):3987-93. PubMed ID: 20679620
[TBL] [Abstract][Full Text] [Related]
2. Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial.
Wrobel G; Mauguen A; Rosolen A; Reiter A; Williams D; Horibe K; Brugières L; Le Deley MC;
Pediatr Blood Cancer; 2011 Jul; 56(7):1071-7. PubMed ID: 21280197
[TBL] [Abstract][Full Text] [Related]
3. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
Woessmann W; Peters C; Lenhard M; Burkhardt B; Sykora KW; Dilloo D; Kremens B; Lang P; Führer M; Kühne T; Parwaresch R; Ebell W; Reiter A
Br J Haematol; 2006 Apr; 133(2):176-82. PubMed ID: 16611309
[TBL] [Abstract][Full Text] [Related]
5. Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study.
Woessmann W; Zimmermann M; Lenhard M; Burkhardt B; Rossig C; Kremens B; Lang P; Attarbaschi A; Mann G; Oschlies I; Klapper W; Reiter A
J Clin Oncol; 2011 Aug; 29(22):3065-71. PubMed ID: 21709186
[TBL] [Abstract][Full Text] [Related]
6. Long-term disease control of refractory anaplastic large cell lymphoma with vinblastine.
Garner R; Li Y; Gray B; Zori R; Braylan R; Wall J; Hunger SP
J Pediatr Hematol Oncol; 2009 Feb; 31(2):145-7. PubMed ID: 19194204
[TBL] [Abstract][Full Text] [Related]
7. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
8. Looking at the seemingly contradictory role of vinblastine in anaplastic large-cell lymphoma from a metronomic perspective.
André N; Pasquier E; Gentet JC; Kamen BA
J Clin Oncol; 2011 Feb; 29(4):e90-1; author reply e92-3. PubMed ID: 21172896
[No Abstract] [Full Text] [Related]
9. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
10. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
Laver JH; Kraveka JM; Hutchison RE; Chang M; Kepner J; Schwenn M; Tarbell N; Desai S; Weitzman S; Weinstein HJ; Murphy SB
J Clin Oncol; 2005 Jan; 23(3):541-7. PubMed ID: 15659500
[TBL] [Abstract][Full Text] [Related]
11. Treatment of children and adolescents with non-Hodgkin's lymphoma (results based on the NHL Berlin-Frankfurt-Münster 90 protocols).
Kavan P; Kabicková E; Gajdos P; Koutecký J; Smelhaus V; Stanková J; McClain KL
Cas Lek Cesk; 1999 Jan; 138(2):40-6. PubMed ID: 10376402
[TBL] [Abstract][Full Text] [Related]
12. Long-term remission of children with relapsed and secondary anaplastic large cell non-Hodgkin lymphoma (ALCL) following treatment with pulsed dexamethasone and low dose etoposide.
Stockklausner C; Behnisch W; Mechtersheimer G; Möller P; Kulozik AE
Pediatr Blood Cancer; 2008 Jan; 50(1):126-9. PubMed ID: 16609950
[TBL] [Abstract][Full Text] [Related]
13. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Seidemann K; Tiemann M; Lauterbach I; Mann G; Simonitsch I; Stankewitz K; Schrappe M; Zimmermann M; Niemeyer C; Parwaresch R; Riehm H; Reiter A;
J Clin Oncol; 2003 May; 21(9):1782-9. PubMed ID: 12721255
[TBL] [Abstract][Full Text] [Related]
14. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
[TBL] [Abstract][Full Text] [Related]
15. Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group.
Alexander S; Kraveka JM; Weitzman S; Lowe E; Smith L; Lynch JC; Chang M; Kinney MC; Perkins SL; Laver J; Gross TG; Weinstein H
Pediatr Blood Cancer; 2014 Dec; 61(12):2236-42. PubMed ID: 25156886
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous anaplastic large cell lymphoma.
Daar G; Küpeli S; Yalçin B; Kesik V; Orhan D; Büyükpamukçu M
Pediatr Hematol Oncol; 2010 Oct; 27(7):558-63. PubMed ID: 20624005
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of short-term and intensive chemotherapy for the treatment of childhood and adolescent B cell non-Hodgkin's lymphoma].
Sun XF; Liu DG; Zhen ZJ; Chen XQ; Xia Y; Wang ZH; He YJ; Guan ZG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):581-4. PubMed ID: 16532964
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with daclizumab of refractory anaplastic lymphoma.
Costa V; Oliva T; Norton L
Pediatr Blood Cancer; 2009 Dec; 53(6):1130-1. PubMed ID: 19598219
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of a child with refractory anaplastic large cell lymphoma following therapy with an antisense oligonucleotide, topotecan, and vinblastine.
Wrobel G; Chaber R; Rygier J; Bonar J; Muszynska-Roslan K; Chybicka A
Hematol Oncol; 2015 Mar; 33(1):52-5. PubMed ID: 21809366
[TBL] [Abstract][Full Text] [Related]
20. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
Burkhardt B; Zimmermann M; Oschlies I; Niggli F; Mann G; Parwaresch R; Riehm H; Schrappe M; Reiter A;
Br J Haematol; 2005 Oct; 131(1):39-49. PubMed ID: 16173961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]